AdvanSix Inc. (NYSE:ASIX – Get Free Report) SVP Achilles B. Kintiroglou sold 363 shares of the stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $31.00, for a total transaction of $11,253.00. Following the sale, the senior vice president now owns 33,238 shares of the company’s stock, valued at $1,030,378. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
AdvanSix Price Performance
AdvanSix stock opened at $29.79 on Tuesday. The stock has a market cap of $795.69 million, a price-to-earnings ratio of 99.30 and a beta of 1.69. The company has a quick ratio of 0.74, a current ratio of 1.39 and a debt-to-equity ratio of 0.31. AdvanSix Inc. has a 12-month low of $20.86 and a 12-month high of $32.04. The business’s 50-day simple moving average is $29.29 and its 200 day simple moving average is $26.57.
AdvanSix (NYSE:ASIX – Get Free Report) last released its quarterly earnings data on Friday, August 2nd. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.13 by $0.35. The business had revenue of $453.48 million during the quarter, compared to the consensus estimate of $426.80 million. AdvanSix had a return on equity of 1.03% and a net margin of 0.57%. During the same quarter in the prior year, the company posted $1.18 earnings per share. As a group, research analysts anticipate that AdvanSix Inc. will post 1.67 earnings per share for the current year.
AdvanSix Dividend Announcement
Institutional Trading of AdvanSix
Several hedge funds have recently added to or reduced their stakes in ASIX. BNP Paribas Financial Markets boosted its holdings in shares of AdvanSix by 89.8% in the first quarter. BNP Paribas Financial Markets now owns 13,203 shares of the company’s stock valued at $378,000 after buying an additional 6,245 shares during the period. Empowered Funds LLC grew its position in shares of AdvanSix by 8.1% in the first quarter. Empowered Funds LLC now owns 132,554 shares of the company’s stock valued at $3,791,000 after purchasing an additional 9,975 shares during the last quarter. Inspire Advisors LLC acquired a new position in AdvanSix in the 1st quarter valued at $200,000. Russell Investments Group Ltd. grew its stake in shares of AdvanSix by 227.0% in the first quarter. Russell Investments Group Ltd. now owns 150,663 shares of the company’s stock valued at $4,309,000 after acquiring an additional 104,587 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System increased its holdings in shares of AdvanSix by 48.0% during the first quarter. State Board of Administration of Florida Retirement System now owns 11,192 shares of the company’s stock worth $320,000 after purchasing an additional 3,630 shares during the period. Institutional investors and hedge funds own 86.39% of the company’s stock.
Wall Street Analyst Weigh In
Separately, StockNews.com raised AdvanSix from a “hold” rating to a “buy” rating in a research note on Monday, August 5th.
Check Out Our Latest Stock Analysis on AdvanSix
AdvanSix Company Profile
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Recommended Stories
- Five stocks we like better than AdvanSix
- Earnings Per Share Calculator: How to Calculate EPS
- Intel: Is Now the Time to Be Brave?
- Stock Splits, Do They Really Impact Investors?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Pros And Cons Of Monthly Dividend Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.